Skip to main content
SpringerLink
Log in

Diagnostic Procedures in the Detection of CNS Metastases from Small Cell Lung Cancer

  • Chapter
Lung Cancer: Basic and Clinical Aspects

Part of the book series: Cancer Treatment and Research ((CTAR,volume 28))

Abstract

Central nervous system (CNS) metastases occur frequently as a complication of small cell carcinoma of the lung (SCLC). Their importance relates primarily to the considerable adverse impact which they exert on the well-being of afflicted patients. Of secondary importance is the possibility that tumor tissue may survive within the confines of the CNS despite eradication of tumor elsewhere in the body, thereby limiting the prospects for long-term survival and cure. This secondary issue was first raised by Hansen in 1973 [1] when it was suggested that an increase in median survival would lead to an increase in the frequency of CNS metastases, as had been the case following improvements in the treatment of acute lymphatic luekemia in children.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hansen HH: Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation? Cancer Chem Rep 4:239, 1973.

    CAS  Google Scholar 

  2. Bunn PA, Nugent JL, Matthews MJ: Central nervous system metastases in small cell bronchogenic carcinoma. Semin Oncol 5:314–322, 1978.

    PubMed  Google Scholar 

  3. Pedersen AG: Diagnostic methods of CNS symptoms in 216 consecutive patients with SCLC. Unpublished data.

    Google Scholar 

  4. Pedersen AG, Bach F, Melgaard B: Frequency, diagnosis and prognosis of spinal cord compression in small cell bronchogenic carcinoma. A review of 817 consecutive patients. Cancer 55:1818–1822, 1985.

    Article  PubMed  CAS  Google Scholar 

  5. Pedersen AG, Hammer M, Hansen M, Sørensen PS: Cerebrospinal fluid vasopressin as a marker of central nervous system metastases from small-cell bronchogenic cardinoma. J Clin Onocl 3:48–53, 1985.

    CAS  Google Scholar 

  6. Pedersen AG, Hansen M, Hummer L, Rogowsky P: Cerebrospinal fluid ACTH as a marker of CNS metastases from small cell carcinoma of the lung. Accepted by Cancer.

    Google Scholar 

  7. Pedersen AG, Marangos P, Becker KL, Gazdar A, Bach F, Hansen HH, Bunn PA: Neuronspecific enolase, Bombesin and Calcitonin in the CSF as markers of CNS metastases from small cell carcinoma. Cancer Chemother Pharmacol Supplement 14: p 28, 1985.

    Google Scholar 

  8. Pedersen AG, Olsen J, Nasiell M: Cytologic diagnosis of meningeal carcinomatosis in patients with small cell carcinoma of the lung. Submitted.

    Google Scholar 

  9. Pedersen AG, Paulson OB, Gyldensted C: Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis. J of Neuro Oncol 3:85–89, 1985.

    CAS  Google Scholar 

  10. Pedersen AG, Bach FW, Nissen M, Bach F: Creatine Kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small cell lung cancer. J Clin Oncol 3:1364–1372, 1985.

    PubMed  CAS  Google Scholar 

  11. Griner PF, Mayewski RJ, Mushlin AI, Greenland P: Selection and interpretation of diagnostic tests and procedures. Ann of Intern Med 94:553–600, 1981.

    Google Scholar 

  12. Crane JM, Nelson M J, Ihde DC, Makuch RW, Glatstein E, Zabell A, Johnston-Early A, Bates HR, Saini N, Cohen MH, Bunn PA: A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer. J Clin Oncol 2:1017–1024, 1984.

    PubMed  CAS  Google Scholar 

  13. Rosen ST, Makuch RW, Lichter AS et al: The role of prophylactic cranial irradiation in preventing central nervous system metastases in small cell lung cancer: Potential benefit restricted to patients in complete response. Am J Med 74:615–624, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Hirsch FR, Pausion OB, Hansen HH, Vraa-Jensen J: Intracranial metastases in small cell carcinoma of the lung. Correlation of clinical and autopsy findings. Cancer 50:2433–2437, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Pedersen AG, Karle A, Boysen G, Hojgaard K, Dombernowsky P: Brain CT-scanning and neurological examination in small cell bronchogenic carcinoma. J of Neuro Oncol 1:197–202, 1983.

    Article  CAS  Google Scholar 

  16. Elliott JA, Østerlind K, Hirsch FR, Hansen HH: Metastatic patterns in small cell lung cancer correlation of autopsy findings with clinical parameters in 537 patients. Submitted.

    Google Scholar 

  17. Hazel GA, Scott M, Eagan RT: The effect of CNS metastases on the survival of patients with small cell cancer of the lung. Cancer 51:933–937, 1983.

    Article  PubMed  Google Scholar 

  18. Komaki R, Cox JD, Holoye PY, Byhardt RW: Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung. Am J Clin Oncol 6:515–521, 1983.

    PubMed  CAS  Google Scholar 

  19. Aroney RS, Aisner J, Wesley MN, Whitacre MY, Van Echo DA, Slawson RG, Wiernik PH: Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 67:675–682, 1983.

    PubMed  CAS  Google Scholar 

  20. Aroney RS, Dalley DN, Chan WK, Bell DR, Levi JA: Meningeal carcinomatosis in small cell carcinoma of the lung. Am J Med 71:26–32, 1981.

    Article  PubMed  CAS  Google Scholar 

  21. Johnson DH, Windham WW, Allen JH, Greco FA: Limited value of CT brain scans in the staging of small cell lung cancer. Am J Roentg 140:37–40, 1983.

    CAS  Google Scholar 

  22. Lininger TR, Fleming TR, Eagan RT: Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer. Cancer 48:2147–2153, 1981.

    Article  PubMed  CAS  Google Scholar 

  23. Chak LY, Daniels JR, Sikic BI, Torti FM, Lockbaum P, Carter SK: Patterns of failure in small eel carcinoma of the lung. Cancer 50:1857–1863, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Joss R, Goldhirsch A, Sonntag R, Brunner K: Metastasen im Bereich des zentralen Nervesystems beim anaplastischen Kleinzelligen Bronchus-karzinom. Schweiz Mea Wschr 111:48–52, 1981.

    CAS  Google Scholar 

  25. Balducci L, Little D, Khansur T, Steinberg MH: Carcinomatous meningitis in small cell lung cancer. Am J Med Sei 287(1):31–33, 1984.

    Article  CAS  Google Scholar 

  26. Feld R, Evans WK, DeBoer G, Quiert IC, Stepherd FA, Yeoh JL, Pringle JF, Payne DG, Herman JG, Chamberlain D, Brown TC, Baker MA, Myers R, Blackstein ME, Pritchard KI: Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol 2: (4)294–304, 1984.

    PubMed  CAS  Google Scholar 

  27. Hirsch FR, Paulson OB, Hansen HH, Larsen SO: Intracranial metastases in small cell carcinoma of the lung. Prognostic aspects. Cancer 51:529–533, 1983.

    Article  PubMed  CAS  Google Scholar 

  28. Komaki R, Cox JD, Whitson W: Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65:811–814, 1981.

    PubMed  CAS  Google Scholar 

  29. Maurer LH, Tulloh M, Weiss RB, Blom J, Leone L, Glidewell O, Pajak TF: A randomized combined modality trial in small cell carcinoma of the lung. Cancer 45:30–39, 1980.

    Article  PubMed  CAS  Google Scholar 

  30. Nugent JL, Bunn PA, Matthews MJ, Ihde DC, Cohen MH, Gazdar A, Minna JD: CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival. Cancer 44:1885–1893, 1979.

    Article  PubMed  CAS  Google Scholar 

  31. Posner JB: Management of central nervous system metastases. Semin Oncol 4:81–91, 1977.

    PubMed  CAS  Google Scholar 

  32. Pedersen AG, Bach F, Kjøler O, Gyldensted C, Grundtvig P, Brå-Jensen J: Diagnostic procedures in patients with small cell bronchogenic carcinoma and neurological symptoms. In preparation.

    Google Scholar 

  33. Chak LY, Paryani SB, Sikic BI, Lockbaum P, Torti FM, Carter SK: Diagnostic accuracies of clinical studies in patients with small cell carcinoma of the lung. J Clin Oncol 1:290–294, 1983.

    PubMed  CAS  Google Scholar 

  34. Poon PY, Feld R, Evans WK, Ege G, Yeoh JL, McLoughlin ML: Computed tomography of the brain, liver and upper abdomen in the staging of small cell carcinoma of the lung. J Comput Assist Tomogr 6(5): 963–965, 1982.

    Article  PubMed  CAS  Google Scholar 

  35. Cruz JM, Jackson DV, White DR, Richards F, Muss HB, Stuart JJ, Cooper MR, Spurr CL, Pope EK, Patterson RB: Evaluation of brain metastasis at presentation of small cell carcinoma (SCC) of the lung. Am Soc Clin Oncol 1:142, 1982.

    Google Scholar 

  36. Levitan N, Byrne R, Licciardello J, Gale E, Levine H, Bromer R, Hong WK: Computerized cranial tomography (CCT) in small cell lung cancer. Am Soc Clin Oncol 2:189, 1983.

    Google Scholar 

  37. Bitran JD, Bekerman C, Pinsky S: Sequential scintigraphic staging of small cell carcinoma. Cancer 47:1971–1975, 1981.

    Article  PubMed  CAS  Google Scholar 

  38. Ihde DC, Makuch RW, Carney DN, Bunn PA, Cohen MH, Matthews MJ, Minna JD: Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy. Am Rev Respir Dis 123:500–507, 1981.

    PubMed  CAS  Google Scholar 

  39. Bydder GM, Pennoch JM, Steiner RE, Orr JS, Bailes DR, Young IR: Thenmar diagnosis of cerebral tumours. J Magn Res Med 1:1–23, 1984.

    Article  Google Scholar 

  40. Bydder GM, Steiner RE, Thomas DJ, Marshall J, Gilderdales DJ and Young IR: Nuclear magnetic resonance imaging of the posterior fossa: 50 cases. Clinical Radiology 34:173–188, 1983.

    Article  PubMed  CAS  Google Scholar 

  41. Randell CP, Collins AG, Young IR, Haywood R, Thomas DJ, McDonnell M J, Orr JS, Bydder GM, Steiner RE: Nuclear magnetic resonance imaging of posterior fossa tumors. Amer Jour Roentg 141:489–496, 1983.

    CAS  Google Scholar 

  42. McGinnis BD, Brady TJ, New PFJ, Buonanno FS, Pykett IL, DeLaPaz RL, Kistler JP, Tavernas JM: Nuclear Magnetic Resonance (NMR) Imaging of Tumors in the Posterior Fossa. J Comput Assist Tomogr 7(4):575–584, 1983.

    Article  PubMed  CAS  Google Scholar 

  43. Beerman WF: Meningeal Carcinomatosis. JAMA 58:1437–1439, 1912.

    Google Scholar 

  44. Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: A clinical and pathologic study. Arch Neurol 30:122–137, 1974.

    PubMed  CAS  Google Scholar 

  45. Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49:759–772, 1982.

    Article  PubMed  CAS  Google Scholar 

  46. Brereton HD, O’Donnell JF, Kent CH, Matthews M, Dunnick NR, Johnson RE: Spinal meningeal carcinomatosis in small-cell carcinoma of the lung. Ann Int Med 88:517–518, 1978.

    PubMed  CAS  Google Scholar 

  47. Rosen ST, Aisner J, Makuch RW, Matthews MJ, Ihde DC, Whitacre M, Glatstein EJ, Wiernik PH, Lichter AS, Bunn PA: Carcinomatous leptomeningitis in small cell lung cancer: A clinicopathologic review of The National Cancer Institute experience. Medicine 61:45–53, 1982.

    Article  PubMed  CAS  Google Scholar 

  48. Pickren JW, Vincent RG: Effect of therapy in lung cancer: An autopsy study. In: Lung Cancer: Progress in therapeutic research. F Muggia and M Rozencweig (eds.) Raven Press, New York 151–154, 1979.

    Google Scholar 

  49. Kokkoris CP: Leptomeningeal carcinomatosis: How does cancer reach the Pia-arachnoid? Cancer 51:154–160, 1983.

    Article  PubMed  CAS  Google Scholar 

  50. Matthews MJ: Effects of therapy on the morphology and behavior of small cell carcinoma of the lung — A clinicopathologic study. In: Lung Cancer: Progress in therapeutic research. F Muggia and M Rozencweig (eds.) Raven Press, New York 155–165, 1979.

    Google Scholar 

  51. Aisner J, Ostrow S, Govindan S, Wiernik P: Leptomeningeal carcinomatosis in small cell carcinoma of the lung. Med Pediatr Oncol 9:47–59, 1981.

    Article  PubMed  CAS  Google Scholar 

  52. Boyle R, Thomas M, Adams JH: Diffuse involvement of the leptomeninges by tumour — a cliical and pathological study of 63 cases. Postgrad Med J 56:149–158, 1980.

    Article  PubMed  CAS  Google Scholar 

  53. Little JR, Dale AJD, Okazaki H: Meningeal carcinomatosis. Clinical manifestations. Arch Neurol 30:138–143, 1974.

    PubMed  CAS  Google Scholar 

  54. Aisner J, Whitacre M, VanEcho DA, Wesley M, Wiernik PH: Doxorubicin, Cyclophosphamide and VP 16–213 (ACE) in the treatment of small cell lung cancer. Cancer Chemother Pharmacol 7:187–193, 1982.

    PubMed  CAS  Google Scholar 

  55. Aisner J, Aisner SC, Ostrow S, Govindan S, Mummert K, Wiernik P: Meningeal carcinomatosis from small cell carcinoma of the lung. Consequence of improved survival. Acta Cytol 23(4): 292–296, 1979.

    PubMed  CAS  Google Scholar 

  56. Hansen HH, Bender RA, Shelton BJ: The cyto-centrifuge and cerebrospinal fluid cytology. Acta Cytol 18:259–262, 1974.

    PubMed  CAS  Google Scholar 

  57. Gondos B: Cytology of cerebrospinal fluid: Technical and diagnosis considerations. Ann Clin Lab Sei 6(2): 152–157, 1976.

    CAS  Google Scholar 

  58. Bigner S, Johnston W: The diagnostic challenge of tumors manifested initially by the shedding of cells into cerebrospinal fluid. Acta Cytol 28(1): 29–36, 1984.

    PubMed  CAS  Google Scholar 

  59. Glass JP, Melamed M, Chernik NL, Posner JB: Malignant cells in the cerebrospinal fluid (CSF): The meaning of a CSF cytology. Neurology 29:1369–1375, 1979.

    PubMed  CAS  Google Scholar 

  60. Choi HH, Anderson PJ: Diagnostic cytology of cerebrospinal fluid by the cytocentrifuge method. Am J Clin Pathol 72:931–943, 1979.

    PubMed  CAS  Google Scholar 

  61. Ehya H, Hajdu S, Melamed M: Cytopathology of nonlymphoreticular neoplasms metastatic to the central nervous system. Acta Cytol 35(6): 599–611, 1981.

    Google Scholar 

  62. Coakham HB, Brownell B, Harper EI, Garson JA, Allan PM, Lane EB: Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet 1096–1098, 1984.

    Google Scholar 

  63. Kristoffersson U, Dahlquist E, Mitelman F: Cytogenetic diagnosis of meningeal carcinomatosis. N Eng J Med 303(25): 1479, 1980.

    Article  CAS  Google Scholar 

  64. Cutler RWP, Spertell RB: Cerebrospinal fluid: A selective review. Ann Neurol 11:1–10, 1982.

    Article  PubMed  CAS  Google Scholar 

  65. Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB: Cerebrospinal fluid biochemical markers in central nervous system tumors: A review. Ann Clin Lab Sei 11(3):239–251, 1981.

    CAS  Google Scholar 

  66. Schold SC, Wasserstrom WR, Fleisher M, Schwartz MK, Posner JB: Cerebrospinal fluid biochemical markers of central nervous system metastases. Ann Neurol 8:597–604, 1980.

    Article  PubMed  CAS  Google Scholar 

  67. Fleisher M, Wasserstrom WR, Schold SC, Schwartz MK, Posner JB: Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer. Cancer 47:2654–2659, 1981.

    Article  PubMed  CAS  Google Scholar 

  68. Hansen M: Clinical implications of ectopic hormone production in small cell carcinoma of the lung. Danish Med Bull 28:221–236, 1981.

    PubMed  CAS  Google Scholar 

  69. Lokich J J: The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinoma. Cancer 50:2111–2114, 1982.

    Article  PubMed  CAS  Google Scholar 

  70. Hansen M, Pedersen AG: Tumor workers in patients with lung cancer. Submitted.

    Google Scholar 

  71. Hansen M, Hansen HH, Almqvist S, Hummer L: Cerebrospinal fluid ACTH and calcitonin in patients with CNS metastases from small cell bronchogenic carcinoma. Europ J Cancer 16:855–857, 1980.

    CAS  Google Scholar 

  72. North WG, Maurer LH, Valtin H, O’Donnell JF: Human Neurophysins as potential tumor markers for small cell carcinoma of the lung: Application of specific radioimmunoassays. J Clin Endocrinol Metab 51:892–896, 1980.

    Article  PubMed  CAS  Google Scholar 

  73. Gazdar AF, Zweig MH, Carney DN, Van Steirteghen AC, Baylin SB, Minna JD: Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Research 41:2773–2777, 1981.

    PubMed  CAS  Google Scholar 

  74. Carney DN, Broder LE, Edelstein M, Gazdar AF, Hansen M, Havemann K, Matthews MJ, Sørenson GD, Vindeløv L: Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67:27–36, 1983.

    PubMed  CAS  Google Scholar 

  75. Carney DN, Marangos PJ, Ihde DC, Cohen MH, Bunn PA, Minna JD, Gazdar AF: Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cnacer. Lancet 1:583–585, 1982.

    Article  PubMed  CAS  Google Scholar 

  76. Baylin SB, Abeloff MD, Goodwin G, Carney DN, Gazdar F: Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in lung cancers and decarboxylase as a marker for small (oat) cell cancer in culture. Cancer Res 40:1990–1994, 1980.

    PubMed  CAS  Google Scholar 

  77. Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JD: High levels of intracellular Bombesin characterize human small cell lung carcinoma. Scinece 214:1246–1248, 1981.

    Article  CAS  Google Scholar 

  78. Marangos P, Gazdar A, Carney D: Neuron-specific enolase in human small cell carcinoma cultures. Cancer Lett 15:67–71, 1982.

    Article  PubMed  CAS  Google Scholar 

  79. Baylin SB, Weisburger WR, Eggleston JC, Mendelson G, Beaven MA, Abeloff MD, Ettinger DS: Variable content of histaminase, L-dopa decarboxylase and Calcitonin in small-cell carcinoma of the lung. N Engl J Med 229:105–110, 1978.

    Article  Google Scholar 

  80. Carney DN, Zweig MH, Ihde DC, Cohen MH, Makuch RW, Gazdar AF: Elevated serum Creatine Kinase BB levels in patients with small cell lung cancer. Cancer Res 44:5399–5403, 1984.

    PubMed  CAS  Google Scholar 

  81. Johnson DH, Marangos PJ, Forbes JT, Hainsworth JD, Welch RV, Hande KR, Greco FA: Potential utility of serum Neuron-specific enolase levels in small cell carcinoma of the lung. Cancer Res 44:5409–5414, 1984.

    PubMed  CAS  Google Scholar 

  82. Becker KL, Silva OL, Post RM, Ballenger JC, Carman JS, Snider RH, Moore CF: Immu-noreactive calcitonin in cerebrospinal fluid of man. Brian Res 194:598–602, 1980.

    Article  CAS  Google Scholar 

  83. Parma AM, Marangos PJ, Goodwin FK: A more sensitive radioimmunoassay for neuron-specific enolase (NSE) suitable for cerebrospinal fluid determination. J Neurochem 36:1093–1097, 1981.

    Article  PubMed  CAS  Google Scholar 

  84. Enzmann DR, Krikorian J, Yorke C, Hayward R: Computed tomography in leptomeningeal spread to tumor. J Comput Assist Tomogr 2:448–455, 1978.

    Article  PubMed  CAS  Google Scholar 

  85. Asscherl GF, Hilal SK, Brisman R: Computed tomography of disseminated meningeal and ependymal malignant neoplasms. Neurology (NY) 31:567–574, 1981.

    Google Scholar 

  86. Ree AH, Jensen LB: Spinal leptomeningeal carcinosis visualized by amipaque myelography. Neuroradiology 17:283–284, 1979.

    Article  PubMed  CAS  Google Scholar 

  87. Oster MW, Fetell M: Meningeal carcinomatosis in small cell carcinoma of the lung. Med Pediatr Oncol 10:157–160, 1982.

    Article  PubMed  CAS  Google Scholar 

  88. Pedersen AG, Nielsen H, Paulson OB: Metrizamid Myelography in Patients with Meningeal Carcinomatosis. Acta Neurol Scand 65 suppl 90:100, 1982 (Abstract).

    Article  Google Scholar 

  89. Murphy KC, Feld R, Evans WK, Shepherd FA, Perrin R, Sima AA, Poon PY: Intramedullary spinal cord metastases from small cell carcinoma of the lung. J Clin Oncol 1:99–106, 1983.

    PubMed  CAS  Google Scholar 

  90. Edelson RN, Deck MDF and Posner JB: Intramedullary spinal cord metastases: Clinical and radiographic findings in nine cases. Neurology 22:1222–1231, 1972.

    PubMed  CAS  Google Scholar 

  91. Smaltino F, Bernini FP and Santoro S: Computerized tomography in the diagnosis of intramedullary metastases. Acta Neurochirurgica 52:299–303, 1980.

    Article  PubMed  CAS  Google Scholar 

  92. Wang A, Lewis ML, Rumbaugh CL, Zamani AA, O’Reilly GV: Spinal Cord or Nerve Root Compression in Patients with Malignant Disease: CT Evaluation. J Comput Assist Tomogr 8:420–428, 1984.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Anders G. Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Oncology II, Finsen Institute, 49 Strandsoulevarden, DK - 2100, Copenhagen, Denmark

    Heine H. Hansen

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Pedersen, A.G. (1986). Diagnostic Procedures in the Detection of CNS Metastases from Small Cell Lung Cancer. In: Hansen, H.H. (eds) Lung Cancer: Basic and Clinical Aspects. Cancer Treatment and Research, vol 28. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2295-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2295-5_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9414-6

  • Online ISBN: 978-1-4613-2295-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation